Loading clinical trials...
Loading clinical trials...
A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions
Interventions
Cetuximab
Nab-paclitaxel
+1 more
Locations
3
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Vanderbilt University
Nashville, Tennessee, United States
University of Washington
Seattle, Washington, United States
Start Date
February 1, 2012
Primary Completion Date
June 20, 2015
Completion Date
December 1, 2019
Last Updated
November 23, 2020
NCT04585750
NCT06636188
NCT07457346
NCT07065630
NCT05526924
NCT07447050
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions